vancomycin has been researched along with coumermycin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tawfik, AF | 1 |
| Barry, AL; Jones, RN; Thornsberry, C | 1 |
| Braveny, I; Machka, K; Milatovic, D | 1 |
| Braveny, I; Machka, K | 1 |
| Joly, P; Van der Auwera, P | 1 |
| Breyer, S; Georgopoulos, A; Hirschl, AM; Rotter, ML; Stanek, G | 1 |
| Chandrasekar, PH; DeLorenzo, W; Levine, DP; Unowsky, J | 1 |
| Dibb, WL; Digranes, A; Salveson, A | 1 |
8 other study(ies) available for vancomycin and coumermycin
| Article | Year |
|---|---|
Effects of vancomycin, teicoplanin, daptomycin and coumermycin on normal immune capabilities.
Topics: Aminocoumarins; Animals; Anti-Bacterial Agents; Coumarins; Daptomycin; Glycopeptides; Humans; Immunity, Cellular; Leukocytes; Male; Mice; Mice, Inbred BALB C; Organ Size; Peptides; Phagocytosis; Spleen; Teicoplanin; Vancomycin | 1991 |
Evaluation of teicoplanin and vancomycin disk susceptibility tests.
Topics: Aminocoumarins; Anti-Bacterial Agents; Bacteria; Corynebacterium; Coumarins; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Enterobacteriaceae; Fusidic Acid; Glycopeptides; Microbial Sensitivity Tests; Pseudomonas; Streptococcus; Teicoplanin; Vancomycin | 1986 |
In vitro interactions of carumonam in combination with coumermycin, teicoplanin, flucloxacillin and vancomycin.
Topics: Aminocoumarins; Anti-Bacterial Agents; Aztreonam; Bacteria; Cloxacillin; Coumarins; Drug Therapy, Combination; Enterobacter; Floxacillin; Glycopeptides; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Serratia marcescens; Teicoplanin; Vancomycin | 1987 |
Comparative in vitro activity of LY146032 (daptomycin) against gram-positive cocci.
Topics: Aminocoumarins; Anti-Bacterial Agents; Coumarins; Daptomycin; Glycopeptides; Microbial Sensitivity Tests; Peptides; Staphylococcus; Streptococcus; Teicoplanin; Vancomycin | 1987 |
Comparative in-vitro activities of teicoplanin, vancomycin, coumermycin and ciprofloxacin, alone and in combination with rifampicin or LM 427, against Staphylococcus aureus.
Topics: Aminocoumarins; Anti-Bacterial Agents; Cell Wall; Ciprofloxacin; Coumarins; DNA-Directed RNA Polymerases; Drug Interactions; Glycopeptides; Humans; Rifabutin; Rifampin; Rifamycins; Staphylococcus aureus; Teicoplanin; Topoisomerase II Inhibitors; Vancomycin | 1987 |
Efficacy of coumermycin, ofloxacin and vancomycin against methicillin-resistant Staphylococcus aureus in vitro and in experimental infections of mice.
Topics: Aminocoumarins; Animals; Anti-Bacterial Agents; Coumarins; Drug Resistance, Microbial; Male; Methicillin; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Ofloxacin; Oxazines; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1988 |
In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureus.
Topics: Aminocoumarins; Animals; Anti-Bacterial Agents; Coumarins; Drug Combinations; Female; Fusidic Acid; Methicillin; Mice; Microbial Sensitivity Tests; Neutropenia; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1986 |
Coumermycin: in vitro activity against 251 clinical isolates of bacteria compared with the activities of eight other antibacterial agents.
Topics: Aminocoumarins; Ampicillin; Anti-Bacterial Agents; Clindamycin; Cloxacillin; Coumarins; Doxycycline; Erythromycin; Gram-Positive Bacteria; Humans; Netilmicin; Penicillin G; Staphylococcus; Streptococcus; Vancomycin | 1986 |